Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential | Zendy

Philippe LagacéWiens | Zendy; Heather J. Adam | Zendy; Nancy M. Laing | Zendy; Melanie Baxter | Zendy; Irene Martín | Zendy; M. R. Mulvey | Zendy; James A. Karlowsky | Zendy; D. J. Hoban | Zendy; George G. Zhanel | Zendy

Open Access

Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential

Author(s) -

Philippe LagacéWiens,

Heather J. Adam,

Nancy M. Laing,

Melanie Baxter,

Irene Martín,

M. R. Mulvey,

James A. Karlowsky,

D. J. Hoban,

George G. Zhanel

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx147

Subject(s) - neisseria gonorrhoeae , antimicrobial , microbiology and biotechnology , anti infective agents , medicine , biology

The prevalence of MDR Neisseria gonorrhoeae is increasing globally and represents a public health emergency. Development and approval of new anti-gonococcal agents may take years. As a concurrent approach to developing new antimicrobials, the laboratory and clinical evaluation of currently licensed antimicrobials not widely used for the treatment of gonorrhoea may provide new options for the treatment of gonococcal infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research